Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder related to bile acid metabolism, primarily caused by CYP27A1 gene mutations, with unique symptoms reported in Indian patients.
Case studies of nine Indian patients demonstrated a range of clinical features, with most displaying neurobehavioral issues and a high incidence of cataracts, while finding less prevalence of parkinsonism and dystonia compared to other regions.
The study emphasizes the necessity for better access to effective treatments like chenodeoxycholic acid, as many patients are receiving inadequate care due to genetic testing limitations and a lack of available therapies in the region.